Clover Health Investments Corp

Company Profile

Clover Health Investments Corp had its IPO on 2001-01-02 under the ticker symbol CLOV.

The company operates in the Healthcare sector and Healthcare Plans industry. Clover Health Investments Corp has a staff strength of 656 employees.

Stock update

Shares of Clover Health Investments Corp opened at $0.88 at the start of the last trading session i.e. 2023-03-25.

The stocks traded within a range of $0.88 - $0.9, and closed at $0.88.

This is a -0.56% slip from the previous day's closing price.

A total volume of 3,778,130 shares were traded at the close of the day’s session.

In the last one week, shares of Clover Health Investments Corp have slipped by -6.02%.

Clover Health Investments Corp's Key Ratios

Clover Health Investments Corp has a market cap of $423.63 million, indicating a price to book ratio of 1.329 and a price to sales ratio of 0.1661.

In the last 12-months Clover Health Investments Corp’s revenue was $3.58 billion with a gross profit of $126.19 million and an EBITDA of $-360659008. The EBITDA ratio measures Clover Health Investments Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Clover Health Investments Corp’s operating margin was -10.1% while its return on assets stood at -25.7% with a return of equity of -76.4%.

In Q4, Clover Health Investments Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 145.7%.

Clover Health Investments Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.67 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Clover Health Investments Corp’s profitability.

Clover Health Investments Corp stock is trading at a EV to sales ratio of 4.3374 and a EV to EBITDA ratio of 0.3762. Its price to sales ratio in the trailing 12-months stood at 0.1661.

Clover Health Investments Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$808.62 million

Total Liabilities

$440.66 million

Operating Cash Flow

$0

Capital Expenditure

$3.88 million

Dividend Payout Ratio

0%

Clover Health Investments Corp ended 2023 with $808.62 million in total assets and $0 in total liabilities. Its intangible assets were valued at $808.62 million while shareholder equity stood at $347.74 million.

Clover Health Investments Corp ended 2023 with $0 in deferred long-term liabilities, $440.66 million in other current liabilities, 37000.00 in common stock, $-1955582000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $103.79 million and cash and short-term investments were $145.25 million. The company’s total short-term debt was $1,827,000 while long-term debt stood at $0.

Clover Health Investments Corp’s total current assets stands at $625.00 million while long-term investments were $138.11 million and short-term investments were $41.46 million. Its net receivables were $23.60 million compared to accounts payable of $32.45 million and inventory worth $0.

In 2023, Clover Health Investments Corp's operating cash flow was $0 while its capital expenditure stood at $3.88 million.

Comparatively, Clover Health Investments Corp paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$0.88

52-Week High

$3.9

52-Week Low

$0.8601

Analyst Target Price

$2.09

Clover Health Investments Corp stock is currently trading at $0.88 per share. It touched a 52-week high of $3.9 and a 52-week low of $3.9. Analysts tracking the stock have a 12-month average target price of $2.09.

Its 50-day moving average was $1.13 and 200-day moving average was $1.76 The short ratio stood at 4.65 indicating a short percent outstanding of 0%.

Around 1284.5% of the company’s stock are held by insiders while 3237.2% are held by institutions.